TFRC depletion significantly diminished the cytotoxic effects of artesunate in vivo, as evidenced by reduced tumor growth in TFRC-deficient xenografts (Fig. 7F, G and Fig. S6B). This evidence concerns the gene TFRC and neoplasm.